Droxidopa 是 Droxidopa (w/w80%) 和 Pharmaceutical starch (w/w20%) 的混合物，能透过血脑屏障，可作为神经递质去甲肾上腺素和肾上腺素的原药。

Droxidopa is an orally available prodrug of norepinephrine that is used in the treatment of symptomatic orthostatic hypotension due to neurogenic causes of autonomic failure.

Droxidopa通过口服给药,吸收后通过酶多巴脱羧酶转化为去甲肾上腺素,与内源性去甲肾上腺素共同增加神经递质水平。Droxidopa也可以穿过血脑屏障（BBB）,并在脑内转化为去甲肾上腺素和肾上腺素。

23651-95-8

C9H11NO5

213.189

L-DOPS;屈昔多巴;SM5688;DOPS;屈西多巴;Droxidopa

DMSO:2.13 mg/ml (10 mM),Need ultrasonic
H2O:1.25mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years